| Literature DB >> 31671082 |
Donald R Hopkins, Adam J Weiss, Sharon L Roy, James Zingeser, Sarah Anne J Guagliardo.
Abstract
Dracunculiasis (also known as Guinea worm disease) is caused by the parasite Dracunculus medinensis and is acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae. The worm typically emerges through the skin on a lower limb approximately 1 year after infection, resulting in pain and disability (1). There is no vaccine or medicine to treat the disease; eradication efforts rely on case containment* to prevent water contamination and other interventions to prevent infection, including health education, water filtration, chemical treatment of unsafe water with temephos (an organophosphate larvicide to kill copepods), and provision of safe drinking water (1,2). In 1986, with an estimated 3.5 million cases† occurring each year in 20 African and Asian countries§ (3), the World Health Assembly called for dracunculiasis elimination (4). The global Guinea Worm Eradication Program (GWEP), led by The Carter Center and supported by the World Health Organization (WHO), CDC, the United Nations Children's Fund, and other partners, began assisting ministries of health in countries with dracunculiasis. This report, based on updated health ministry data, describes progress to eradicate dracunculiasis during January 2018-June 2019 and updates previous reports (2,4,5). With only five countries currently affected by dracunculiasis (Angola, Chad, Ethiopia, Mali, and South Sudan), achievement of eradication is within reach, but it is challenged by civil unrest, insecurity, and lingering epidemiologic and zoologic questions.Entities:
Mesh:
Year: 2019 PMID: 31671082 PMCID: PMC6822808 DOI: 10.15585/mmwr.mm6843a5
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Number of reported indigenous dracunculiasis cases, by country –– worldwide, January 2017–June 2019
| Country | No. of cases (% contained) | % change in no. of cases, Jan–Dec 2017 to Jan–Dec 2018 | No. of cases (% contained) | % change in no. of cases, Jan–Jun 2018 to Jan–Jun 2019 | ||
|---|---|---|---|---|---|---|
| Jan–Dec 2017 | Jan–Dec 2018 | Jan–Jun 2018 | Jan–Jun 2019 | |||
|
| ||||||
| Chad | 15 (67) | 17 (41) | +13 | 4 (100) | 23 (61) | +475 |
| Ethiopia | 15 (20) | 0 | −100 | 0 | 0 | 0 |
| Mali* | 0 | 0 | 0 | 0 | 0 | 0 |
| South Sudan | 0 | 10 (30) | NA | 4 (0) | 0 | −100 |
| Angola | 0 | 1 (0) | NA | 1 (0) | 1 (0) | 0 |
| Cameroon† | 0 | 0 | 0 | 0 | 1 (0) | NA |
|
|
|
|
|
|
|
|
|
| ||||||
| Chad | 830 (75) | 1,065 (75) | +28 | 696 (74) | 1,356 (78) | +95 |
| Ethiopia | 15 (40) | 17 (41) | +13 | 10 (70) | 6 (0) | −40 |
| Mali* | 10 (80) | 20 (80) | +100 | 3 (67) | 0 | −100 |
| Angola | 0 | 0 | 0 | 0 | 1 (0) | NA |
|
|
|
|
|
|
|
|
Abbreviation: NA = not applicable.
* Civil unrest and insecurity resulting from a coup d’état in April 2012 continued to constrain program operations in regions with endemic dracunculiasis (Gao, Kidal, Mopti, and Timbuktu) during January 2017–June 2019.
† Final classification of case origin pending further investigation.
§ In Chad, primarily dogs, some cats; in Ethiopia, dogs, cats, and baboons; in Mali, dogs and cats; in Angola, one dog.
¶ No international importations of animal infections were reported during the 18-month period January 2018–June 2019.
Characteristics of specimens from humans and animals received at CDC for laboratory diagnosis of Dracunculus medinensis — January 2018–June 2019
| Specimens received at CDC | Jan–Dec 2018 | Jan–Jun 2019 |
|---|---|---|
|
| ||
| No. received | 89 | 39 |
| No. laboratory-confirmed as | 38 (43) | 16 (41) |
|
| ||
| Angola | 1 (1) | 1 (1) |
| Chad | 21 (17)* | 15 (15) |
| Ethiopia | 1 (1)§ | — |
| South Sudan | 15 (10) | — |
|
| 51 (57) | 23 (59) |
|
| ||
| Mermithid | 7 (14) | 1 (4) |
|
| 5 (10) | 2 (9) |
| Sparganum | 5 (10) | 10 (43) |
| Earthworm | 3 (6) | — |
|
| 1 (2) | — |
| Ascarid | 1 (2) | — |
|
| — | 1 (4) |
| Worm of unknown species | 7 (14) | 1 (4) |
| Connective tissue | 13 (25) | 6 (26) |
| Unknown origin | 9 (18) | 2 (9) |
|
| ||
| No. received | 60 | 7 |
| No. laboratory-confirmed as | 53 (88) | 5 (71) |
|
| ||
|
| — | 3 |
| Dog | — | 3 (1) |
|
| 8 | — |
| Cat | 2 (2) | — |
| Dog | 6 (6) | — |
|
| 25 | 1 |
| Baboon | 6 (1) | 1 (1) |
| Cat | 6 (5) | — |
| Dog | 13 (11) | — |
|
| 20 | 1 |
| Cat | 2 (2) | — |
| Dog | 18 (18) | 1 (1) |
|
| 7 (12) | 2 (29) |
|
| ||
| Ascarid | 1 (14) | — |
|
| — | 1 (50) |
|
| 1 (14) | — |
|
| 1 (14) | — |
| Sparganum | 1 (14) | — |
| Worm of unknown species | 3 (43) | — |
| Unknown origin | — | 1 (50) |
* 19 worms from 16 patients in 2018 and two worms from one patient who had emerging worms in 2017.
† 14 worms from 14 patients in 2019 and one worm from one patient in 2018.
§ One worm from one patient in 2017.
Reported human and animal dracunculiasis cases, active surveillance, and status of local interventions in villages with endemic disease, by country — worldwide, 2018
| Human cases/Surveillance/Intervention status | Country | Total | ||||
|---|---|---|---|---|---|---|
| Chad* | Ethiopia | Mali† | South Sudan | Angola | ||
|
| ||||||
| No. indigenous, 2018 | 17 | 0 | 0 | 10 | 1 | 28 |
| No. imported,§ 2018 | 0 | 0 | 0 | 0 | 0 | 0 |
| % contained¶ in 2018 | 41 | 0 | 0 | 30 | 0 | 36 |
| % change in indigenous human cases in villages/localities under surveillance, same period, 2017 and 2018 | +13 | −100 | 0 | NA | NA | −7 |
|
| ||||||
| No. indigenous, 2018 | 1,065 | 17 | 13 | 0 | 0 | 1,095 |
| No. imported,** 2018 | 0 | 0 | 7 | 0 | 0 | 7 |
| % contained¶ in 2018 | 75 | 41 | 80 | 0 | 0 | 74 |
| % change in indigenous animal cases in villages/localities under surveillance, same period, 2017 and 2018 | +28 | +13 | +100 | 0 | 0 | +29 |
|
| ||||||
| No. of villages | 1,895 | 156 | 903 | 2,121 | 0 | 5,075 |
| % reporting monthly | 99 | 100 | 99 | 92 | 0 | 96 |
| No. reporting ≥1 human case | 11 | 0 | 0 | 10 | 1 | 22 |
| No. reporting only imported** human cases | 0 | 0 | 0 | 0 | 1 | 1 |
| No. reporting indigenous human cases | 11 | 0 | 0 | 10 | 0 | 21 |
| No. reporting ≥1 animal case | 335 | 8 | 18 | 0 | 0 | 361 |
| No. reporting only imported** animal cases | 0 | 0 | 3 | 0 | 0 | 3 |
| No. reporting indigenous animal cases | 335 | 8 | 12 | 0 | 0 | 355 |
|
| ||||||
| No. of villages with endemic human dracunculiasis, 2017–2018 | 24 | 1 | — | 10 | 1 | 36 |
| % reporting monthly†† | 100 | 100 | — | 100 | — | 100 |
| % with filters in all households†† | 100 | 100 | — | 100 | — | 100 |
| % using temephos†† | 55 | 100 | — | 100 | — | 67 |
| % with ≥1 source of safe water†† | 71 | 0 | — | 50 | 100 | 64 |
| % provided health education†† | 100 | 100 | — | 100 | 100 | 100 |
|
| ||||||
| No. of villages with endemic animal dracunculiasis, 2017–2018 | 442 | 10 | 15 | — | — | 467 |
| % reporting monthly†† | 100 | 100 | 100 | — | — | 100 |
| % using temephos†† | 24 | 100 | 100 | — | — | 28 |
| % provided health education†† | 100 | 100 | 100 | — | — | 100 |
Abbreviation: NA = not applicable.
* Participants at the annual Chad Guinea Worm Eradication Program review meeting in November 2014 adopted “1+ case village” as a new description for villages in Chad affected by human cases of Guinea worm disease and/or dogs infected with Guinea worms and defined it as “a village with one or more indigenous and/or imported cases of Guinea worm infections in humans, dogs, and/or cats in the current calendar year and/or previous year.”
† Civil unrest and insecurity resulting from a coup d’état in 2012 continued to constrain Guinea Worm Eradication Program operations (supervision, surveillance, and interventions) in Gao, Kidal, Mopti, Segou, and Timbuktu regions.
§ Imported from another country.
¶ Transmission from a patient with dracunculiasis is contained only if all of the following conditions are met for each emerging worm: 1) the infected patient is identified ≤24 hours after worm emergence; 2) the patient has not entered any water source since the worm emerged; 3) a village volunteer or other health care provider has managed the patient properly, by cleaning and bandaging the lesion until the worm has been fully removed manually and by providing health education to discourage the patient from contaminating any water source (if two or more emerging worms are present, transmission is not contained until the last worm is removed); 4) the containment process, including verification of dracunculiasis, is validated by a Guinea Worm Eradication Program supervisor within 7 days of emergence of the worm; and 5) temephos is used to treat potentially contaminated surface water if any uncertainty about contamination of these sources of drinking water exists, or if a such a source of drinking water is known to have been contaminated.
** Imported from another in-country village with endemic disease.
†† The denominator is the number of villages/localities where the program applied interventions during 2017–2018.